borderline significantP = 0.053
In contrast, a borderline significant increase of 39% ( P = 0.053) in the relative risk of acute pancreatitis was seen with fibrate use across seven trials ( N = 40,162) with a mean follow-up period of 5.3 years.
In contrast, a borderline significant increase of 39% ( P = 0.053) in the relative risk of acute pancreatitis was seen with fibrate use across seven trials ( N = 40,162) with a mean follow-up period of 5.3 years.